Standard manages its founding family’s shareholdings.

 

Preserving a century-long legacy of dedication and industry, we invest alongside remarkable entrepreneurs who, like us, believe in hard work, humility, steadfastness and generational ownership.

Latest News

August 2025

Generation Bio to Review Strategic Alternatives 

June 2025

Topicus.com Inc. Completes Acquisition of Cipal Schaubroeck in Belgium

April 2025

Tessenderlo Group Reports 2024 Results 

March 2025

Knight Therapeutics to Acquire Paladin Pharma